OGT-CDG is characterized by a spectrum of clinical features, with the most prominent being intellectual disability (ID) and neurodevelopmental delay (50, 52, 53, 54, 55, 56, 57), suggesting that the underlying molecular defects in OGT are critical for proper brain development and/or function. This evidence concerns the gene OGT and congenital disorder of glycosylation.